Pharmadrug Inc. PHRX
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -463.90K | -340.30K | -274.00K | -174.00K | -243.60K |
| Total Depreciation and Amortization | 36.40K | 36.40K | 36.00K | 36.00K | 36.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 302.10K | 180.10K | 103.30K | 97.40K | 148.00K |
| Change in Net Operating Assets | 60.30K | 24.60K | 71.80K | -29.50K | -9.30K |
| Cash from Operations | -65.30K | -99.30K | -63.00K | -70.20K | -69.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -8.60K | -8.60K |
| Cash from Investing | -- | -- | -- | -8.60K | -8.60K |
| Total Debt Issued | 94.90K | 94.90K | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -91.60K | -91.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 87.20K | 87.20K |
| Cash from Financing | 69.20K | 69.20K | -- | -3.20K | -3.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -1.70K | -1.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.90K | -30.10K | -63.00K | -83.60K | -82.40K |